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The Lectin-Like NK Cell Receptor Ly-49A
Recognizes a Carbohydrate-Independent Epitope
on Its MHC Class I Ligand
absent (nonself) MHC class I molecules on potential
cellular targets.
Recent studies indicate that this MHC class I±depen-
dent resistance to NK lysis is mediated by surface NK
cell receptors that engage target cell MHC class I (Par-
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globally inhibited from killing targets through the recruit-St. Louis, Missouri 63110
ment of the intracellular tyrosine phosphatase, SHP-1,²Laboratory of Immune Cell Biology
that presumably dephosphorylates signaling moleculesNational Cancer Institute
involved in activation (Burshtyn et al., 1996). Two struc-Bethesda, Maryland 20892
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inhibitory receptors (KIR) are type I integral membraneInstitut Pasteur
proteins with Ig-like domains (Colonna and Samaridis,Paris 75724
1995; Wagtmann et al., 1995). The other type includesFrance
the mouse Ly-49 family (Chan and Takei, 1989; Yokoyama§Laboratory of Immunology
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are expressed as disulfide-linked dimers with type II
membrane orientation and contain external domains that
are homologous to the superfamily of Ca21-dependent
Summary lectins, several of which bind carbohydrate determinants
on glycoprotein ligands (Drickamer and Taylor, 1993).
The mouse NK inhibitory Ly-49A receptor specifically In the mouse, several lines of evidence demonstrate
interacts with a peptide-induced conformational de- the MHC class I specificity of the lectin-like Ly-49A re-
ceptor that is expressed on an NK cell subpopulationterminant on its MHC class I ligand, H-2Dd. In addition,
(Yokoyama et al., 1995). Ly-49A1 NK cells were in-it binds the polysaccharide fucoidan, consistent with
capable of killing targets expressing endogenous orits C-type lectin homology and the hypothesis that
transfected H-2Dd, even though such targets remainedLy-49A interacts with carbohydrates on Dd. Herein,
susceptible to killing by Ly-49A2 NK cells (Karlhofer ethowever, we demonstrate that Ly-49A recognizes Dd
al., 1992). Adhesion assays demonstrated that Ly-49Amutants lacking N-glycosylation. Fucoidan competes
directly engaged Dd because cell binding occurred onlyfor binding with anti-Ly-49A antibodies that inhibit Ly-
if one cell expressed Ly-49A by transfection and the49A±Dd interaction, and blocks apparent Ly-49A bind-
other expressed Dd also by transfection (Daniels et al.,ing to unglycosylated Dd. We confirm that Ly-49A rec-
1994a). Similarly, Ly-49A1 cells bound specifically toognizes the a1 and amino-terminal a2 domains of Dd
immobilized purified Dd (Kane, 1994). In the cytotoxicityby analysis of recombinant H-2Kd-H-2Dd molecules.
and binding studies, the interaction was blocked byThese studies indicate that Ly-49A recognizes carbo-
MAbs specific for either molecule, permitting lysis orhydrate-independent epitope(s) on Dd and suggest that
preventing cell adhesion, respectively. As an indicationLy-49A has two distinct ligands, carbohydrate and
of an apparent in vivo extracellular interaction betweenMHC class I.
these molecules, the expression of Ly-49A on NK cells
was also down-regulated in MHC-congenic, recombi-
Introduction nant congenic, and transgenic mice expressing Dd
(Sykes et al., 1993; Karlhofer et al., 1994). Ly-49A also
Natural killer (NK) cells lyse cellular targets including appears to interact with another MHC class I ligand, Dk
certain transformed tumor cells and cells infected with (Karlhofer et al., 1992, 1994) but not with H-2Kd or Ld.
intracellular pathogens in a process termed natural kill- Recent gene transfer studies affirmed these findings.
ing (Trinchieri, 1989). MHC class I molecules protect tar- Expression of Ly-49A on an NK cell by in vitro transfec-
gets from natural killing,whereas targets that specifically tion (Nakamura et al., 1997) or as a result of transgene
lack MHC class I expression are more susceptible to expression (Held et al., 1996) conferred specific Dd inhib-
NK cells (Ljunggren and KaÈ rre, 1990). To explain this itory activity to the NK cell. Thus, Ly-49A is an NK cell
receptor specific for Dd (and Dk).phenomenon, it has been hypothesized that NK cells
Indirect evidence suggests that Ly-49A specificallysurvey tissues for the normal expression of MHC class
interacts with the a1/a2 domains of H-2Dd. The func-I. In the absence of MHC class I or under conditions of
tional activity of Ly-49A in killing experiments, andits dysregulated expression, NK cells are released from
the adhesion of Ly-49A1 cells to Dd transfectants areits inhibitory influence and kill the target. Thus, in accord
blocked by a MAb directed against the a1/a2 domainswith the ªmissing selfº hypothesis, NK cells can appar-
of Dd (Karlhofer et al., 1992). In contrast, a MAb specificently distinguish between normal (self) and aberrant or
for the membrane-proximal a3 domain has no blocking
effect. In the in vivo expression system, Ly-49A is down-
regulated in B10.D2dm1 mice that display a chimeric mol-‖ To whom correspondence should be addressed (e-mail: yokoyama
@imgate.wustl.edu). ecule consisting of a1 and the NH2-terminal half of a2
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domain of Dd (residues 1±154), while the rest of the dm1 addition. Amino acid sequence analysis revealed that
molecule is H-2Ld (Sun et al., 1985; Karlhofer et al., 1994). Dd contains two unique N-glycosylation sites at Asn-86
Since Ld does not interact with Ly-49A in the cytotoxicity and Asn-176 (not shown). Either one or both were mutated
and cell binding assays (Karlhofer et al., 1992; Daniels to Gln, producing the N86Q and N176Q single mu-
et al., 1994a), these results also suggest that Ly-49A tants and the N86,176Q double mutant that were then
interacts with the a1/a2 domains of Dd. Together, these stably transfected into C1498 cells. Positive clones were
findings raised the possibility that Ly-49A mayrecognize screened by FACS analysis, and multiple transfectants
peptides bound to MHC class I. However, there is no were analyzed for each construct. Cells transfected with
specific endogenous peptide that appears to be recog- either construct containing the N86Q mutation have sig-
nized (Correa and Raulet, 1995), and alanine-substituted nificantly lower expression of Dd than wild-type Dd and
peptides, retaining only the minimal anchor residues N176Q single mutant transfectants (Figure 1A). This may
required for binding, stabilized Dd molecules on Dd- reflect an influence of the N-linked carbohydrates at
transfected, TAP-deficient cells and conferred specific Asn-86 (and possibly the contribution of carbohydrates
resistance to killing by Ly-49A1 NK cells (Orihuela et al., at Asn-176 when Asn-86 is absent) in the interaction of
1996). On the other hand, ªemptyº Dd molecules are not Dd with calnexin, which facilitates MHC class I heavy
apparently recognized by Ly-49A, suggesting that Ly- chain folding and assembly (York and Rock, 1996).
49A is not peptide-specific and that it recognizes a pep- N-glycosidase F treatment to remove N-linked carbohy-
tide-induced conformational determinant on Dd. drates from immunoprecipitated cell surface±biotiny-
Other studies, however, indicate that Ly-49A is a lated Dd confirmed that the Asn mutations abrogated
C-type lectin. Not only does it have amino acid sequence N-glycosylation (Figure 1B). This was particularly appar-
similarity to the lectins (Yokoyama et al., 1989), but Ly- ent for the double-mutant N86,176Q molecule, which
49A binds carbohydrates, such as fucoidan (Daniels et had the same mobility on SDS±PAGE in its untreated
al., 1994b). Moreover, fucoidan blocked the interaction form as either N-glycosidase-treated wild-type Dd or
between Ly-49A and Dd, leading to the previous conclu- single-mutant molecules (Figure 1B). Treatment of the
sion that Ly-49A recognizes carbohydrate moieties on double mutant with N-glycosidase had no effect on its
peptides bound to Dd or on Dd itself. Ly-49A does not
migration, confirming that there are no other N-glycosyl-
appear to recognize glycosylated peptides bound to the
ation sites on Dd.
MHC molecule since synthetic peptides lacking carbo-
We next tested the functional activity of theDd mutants
hydrates conferred resistance to Dd, TAP-deficient cells
in cytotoxicity assays with Ly-49A1 and Ly-49A2 LAKfrom killing by Ly-49A1 NK cells (Correa and Raulet,
cells. Ly-49A1 LAK cells were unable to efficiently kill
1995; Orihuela et al., 1996). On the otherhand, inasmuch
C1498 cells transfected with either wild-type Dd or Ddas mouse MHC class I molecules have conserved their
molecules containing either single or double N-glycosyl-N-glycosylation sites in the a1 and a2 domains, the
ation site mutations (Figure 1C). Importantly, this lackhypothesis that Ly-49A recognizes carbohydrate moi-
of cytotoxicity occurred despite the lower level of ex-eties linked to these sites would have accounted for
pression of the single- or double-mutant Dd moleculesmost of the previous data, including inhibition of Ly-49A
containing the N86Q mutation. In contrast, the Dd trans-recognition when targets were treated by tunicamycin
fectants, including all three N-glycosylation site mu-(Daniels et al., 1994b). However, tunicamycin blockade
tants, were efficiently killed by Ly-49A2 LAK cells. More-of N-linked carbohydrate addition is not specific to MHC
over, untransfected C1498 and Kd transfectants wereclass I, leaving open other interpretations, such as ef-
efficiently killed by Ly-49A1 LAK cells in a manner com-fects on other molecules required for cell±cell interac-
parable to killing by Ly-49A2 LAK cells, indicating thattion. In this study, we have directly addressed the hy-
the Ly-49A1 LAK cells have a similar killing capacity, aspothesis that Ly-49A interacts with carbohydrate on
previously demonstrated (Karlhofer etal., 1992). Further-MHC class I by using mutant MHC class I molecules
more, the apparent ability of Dd and its N-glycosylationthat lack N-linked carbohydrates or that are chimeric
mutants to inhibit cytolysis was specifically abrogatedbetween H-2Dd and Kd. Most surprisingly, Ly-49A recog-
by addition of anti-Ly-49A antibody (Figure 1C) or F(ab9)2nizes a carbohydrate-independent epitope on H-2Dd.
fragments of anti-Dd a1/a2 antibody (data not shown).Moreover, the data suggest that Ly-49A recognizes two
Finally, all of these results were seen with multiple, inde-distinct ligands, carbohydrate and MHC class I. These
pendently derived transfectants. These findings stronglystudies raise the possibility that carbohydrate ligands
suggest that Ly-49A molecules on LAK cells can func-for Ly-49A may provide physiologic signals to inhibit
tionally recognize Dd molecules that lack N-linked carbo-NK cell activity and that therapeutic manipulation of
hydrate modification.carbohydrate ligands could alter NK cell function by
affecting NK cell receptor interaction with MHC class I.
Specific Carbohydrate Binding to Ly-49AResults
In view of the findings that Ly-49A may recognize un-
glycosylated forms of Dd, we reexplored the carbohy-Inhibitory Activity of N-Linked Glycosylation
drate binding activities of Ly-49A. Although Fl-fucoidanMutants of H-2Dd against Killing
binds to untransfected CHO cells, we reaffirmed that Fl-by Ly-49A1 LAK Cells
fucoidan binds more strongly to Ly-49A1 CHO cells inTo specifically analyze the influence of carbohydrate
a dose-dependent manner and established that thehalf-associated with H-2Dd molecules on recognition by Ly-
maximal binding of Fl-fucoidan to Ly-49A1 CHO was49A, we generated constructs in which the N-glycosyla-
tion sites in Dd were altered to prevent carbohydrate achieved at 15 mg/ml (85 nM) and maximum binding
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Figure 1. H-2Dd N-Glycosylation Mutants Spe-
cifically Inhibit Killing by Ly-49A1 LAK Cells
(A) Expression of wild-type or mutant Dd mol-
ecules on C1498 transfectants. Cells were
stained with anti-Dd a3 domain±specific MAb
34-2-12 (bold line) or isotype-matched con-
trol MAb MAR (dotted line) and then with
FITC-labeled F(ab9)2 fragments of goat anti-
mouse IgG antibody.
(B) Immunoprecipitation analysis of the Dd
mutants. Cells were surface-biotinylated and
Dd was immunoprecipitated with MAb 34-
2-12. Aliquots of immunoprecipitates were
digested with N-glycosidase F to remove
N-linked carbohydrates. To obtain a similar
signal level, immunoprecipitates from 7.5 3
105, 4 3 106, 2 3 106, and 1 3 107 cell equiva-
lents were loaded for wild-type H-2Dd, Dd
N86Q, Dd N176Q, and Dd N86,176Q transfec-
tants, respectively.
(C) C1498 transfected with wild-type H-2Dd or
the Dd N-glycosylation mutants were assayed
for their susceptibility to killing by Ly-49A1 or
Ly-49A2 LAK cells. As indicated, LAK cells
were preincubated with medium alone, anti-
Ly-49A (A1), or isotype-matched control Ab
(MAR) at the final concentration of 10 mg/ml
for 20 min before mixing with target cells.
was obtained at 80 mg/ml (440 nM) (data not shown). unpublished data). Although it remains possible that the
results are due to distant conformational or steric ef-Furthermore, we demonstrated that binding of Fl-
fucoidan to Ly-49A1 CHO was inhibited by the anti-Ly- fects, these data are consistent with the interpretation
that the same portion of the Ly-49A molecule is used49A antibody A1, indicating specific binding of fucoidan
by Ly-49A (Figure 2A, thin solid line). Among three other both for Dd interaction and for carbohydrate binding.
anti-Ly-49A-specific antibodies, YE1/48 and JR9.318 in-
hibited binding of Fl-fucoidan to a similar degree as did Ly-49A-Carbohydrate-Independent Binding
to H-2Dd Inhibited by CarbohydrateA1 (data not shown), while YE1/32 inhibited the binding
to a lesser degree (Figure 2A, dotted line). A control The interpretation that the same domain of Ly-49A inter-
acts with both Dd and carbohydrate appeared to beantibody, MAR, did not affect the binding (data not
shown). In contrast, Ly-49A-independent binding of Fl- incongruous with our finding that Ly-49A does not react
with the N-linked carbohydrates on Dd. One possiblefucoidan to untransfected CHO cells was unaffected by
any of the anti-Ly-49A antibodies or control antibody explanation is that Ly-49A has two distinct ligands. To
explore this issue further, we could not use functional(Figure 2A, lower panel and data not shown). These
results demonstrate the specificity of fucoidan binding 51Cr-release assays because of the global inhibitory ac-
tivity of fucoidan on killing ability of LAK cells (data notto Ly-49A.
Reciprocal experiments were consistent with these shown). While this effect of fucoidan is unexplained and
could be related to effects on other C-type lectins on NKresults. We examined whether fucoidan could inhibit
binding of anti-Ly-49A antibodies to Ly-49A. Preincuba- cells, we were able to use physical cell binding assays to
examine the interaction between Ly-49A and Dd. C1498tion of Ly-49A1 CHO cells with fucoidan inhibited the
binding of FITC-conjugated MAb A1 in a dose-depen- cells transfected with either wild-type Dd or any of its
N-glycosylation mutants bound to Ly-49A1 CHO cellsdent manner (Figure 2B). Fucoidan at 15 mg/ml inhibited
binding of FITC-A1 almost completely, while another (Figure 3), confirming the specificity of interaction in the
cytotoxicity experiments.complex anionic polysaccharide, mannan, had no effect
on binding of FITC-A1 to Ly-49A1 CHO cells at the same Although the double N86,176Q mutant transfectants
express less Dd, they bound to Ly-49A1 CHO cells in aconcentration, consistent with the binding specificity of
Ly-49A for certain carbohydrates. Moreover, the binding manner comparable to wild-type Dd transfectants (Fig-
ure 3). Binding specificity was confirmed by inhibitionof other Ly-49A-specific MAbs, YE1/48, YE1/32, and
JR9.318, was also inhibited by fucoidan. Importantly, by anti-Ly-49A or anti-Dd a1/a2 antibody (Figure 3). Most
importantly, the binding of C1498 cells transfected withall anti-Ly-49A-specific MAbs can block the interaction
between Ly-49A and Dd, permitting killing or blocking the N86,176Q mutant of Dd was inhibited by fucoidan but
not by mannan (Figure 3), suggesting that the interactioncell binding (Brennan et al., 1996) (N. M. and W. M. Y,
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recognize both a carbohydrate-independent ligand (Dd)
and carbohydrate and that the same portion of Ly-49A
is involved in recognition of both ligands.
Region of H-2Dd Recognized by Ly-49A
To confirm that Ly-49A recognizes the polypeptide
structure of H-2Dd in the absence of carbohydrates on
Dd and to map the region of the polypeptide recognized
by Ly-49A, we used MHC class I molecules with intrado-
main recombinations between Dd and Kd (Figure 4A),
which is not recognized by Ly-49A (Karlhofer et al.,
1992). The constructs tested include ten different re-
combinants (R1±R10) in the a1 and a2 domains of the
MHC class I molecules (Abastado et al., 1987). C1498
cells were stably transfected with the chimeric con-
structs and were assayed by FACS analysis for specific
expression of an epitope in the a3 domain of Dd, which
is retained in the chimeric molecules. Clones that ex-
pressed the chimeric molecules at similar or higher lev-
els than cells transfected with wild-type Dd were se-
lected as the target cells to test their susceptibility to
killing by Ly-49A1 LAK cells (Figure 4B). Individual trans-
fections of C1498 cells with R1±R5 chimeras resulted
in protection from killing by Ly-49A1 LAK cells (Figure
5). However, the protection was only partial when com-
Figure 2. Anti-Ly-49A Antibodies and Fucoidan Compete for Bind- pared to wild-type Dd transfectants with the most potent
ing to Ly-49A
protection resulting from the R2 chimera (Figure 5). The
(A) Inhibition of fucoidan binding to Ly-49A1 CHO cells by anti-Ly-
inhibition was specific because the R1±R5 transfectants49A antibodies. Stably transfected Ly-49A1 CHO cells or un-
were efficiently killed by Ly-49A2 LAK cells. In contrast,transfected CHO cells were incubated with 40 mg/ml of Fl-fucoidan
untransfected C1498 cells and all transfectants with thein the presence or absence (bold line) of an excess amount (15 mg/
ml) of fucoidan (dotted line), 50 mg/ml A1 (thin line),or YE1/32 (broken R6±R10 recombinants and wild-type Kd were efficiently
line). Other Ly-49A-specific MAbs (YE1/48 and JR-9) inhibited Fl- killed by Ly-49A1 LAK cells as well as Ly-49A2 LAK cells.
fucoidan binding to the same degree as MAb A1 but are not shown Furthermore, the anti-Ly-49A antibody A1 reversed the
for clarity. Control antibody MAR at 50 mg/ml did not affect the
inhibitory effect of the R1±R5 recombinants as well asbinding (not shown for clarity).
that of wild-type Dd (Figure 6 and data not shown), indi-(B) Inhibition of anti-Ly-49A antibodies binding to Ly-49A1 CHO cells
cating that the recognition of these recombinants wasby fucoidan. Ly-49A1 CHO cells were stained with FITC-conjugated
anti-Ly-49A MAbs in the presence of indicated concentration of mediated by Ly-49A. Similar results were obtained with
fucoidan or maximum concentrations of a control carbohydrate, multiple transfectants for each chimeric molecule (data
mannan. FITC-A1 was used at 5 mg/ml, and the others were used not shown), demonstrating reproducibility. These re-
at 2 mg/ml. The data are presented as percent of specific control,
sults indicate that Ly-49A recognizes epitope(s) on thewith 100% being the measurement in medium alone after subtrac-
polypeptide backbone of Dd with contributions from Ddtion of nonspecific binding as determined in the presence of more
residues 1±107.than 80-fold excess of the respective unlabeled antibody. Means
of duplicate samples are presented. These data are representative
of three independent assays with similar results. Discussion
Despite homology of the MHC class I±specific NK cellbetween Ly-49A and its unglycosylated MHC class I
ligand may be inhibited by a specific carbohydrate li- receptor, Ly-49A, to C-type lectins, and the previous
demonstration that Ly-49A can bind carbohydrates thatgand. It remains possible that the current findings are
due to effects on other carbohydrate interactions. Nev- was extended here, we have show that carbohydrate is
not necessary for the interaction of Ly-49A with its MHCertheless, these data support the thesis that Ly-49A may
Figure 3. Binding of H-2Dd with N86,176Q
Mutation to Ly-49A Is Inhibited by Fucoidan
Binding of C1498 transfected with wild-type
Dd or Dd glycosylation mutants to Ly-49A1
CHO cells was determined. Anti-Ly-49A anti-
body (A1) anti-Dd a1/a2 antibody (34-5-8S),
anti-Dd a3 (34-2-12), or control antibody
(MAR) were used at the final concentration of
10 mg/ml. Fucoidan and mannan were used
at 20 mg/ml. Means and standard deviations
from triplicate samples are shown. Results
shown are representative of five independent
experiments.
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class I ligand, H-2Dd. Although the current data do not
exclude the possibility that carbohydrates could affect
the affinity of Ly-49A for Dd, our data suggest that Ly-
49A apparently has two distinct ligands, carbohydrate
and a carbohydrate-independent epitope on its MHC
class I ligand. Studies of another C-type lectin with a
type II integral membrane orientation, CD23, are consis-
tent with this interpretation. CD23 (FceRII) binds an epi-
tope on the Fc region of IgE in a carbohydrate-indepen-
dent manner (Vercelli et al., 1989). However, it also binds
glycosylated forms of CD21 in carbohydrate-dependent
fashion (Aubry et al., 1994). Interestingly, the same re-
gion (carbohydrate recognition domain,or CRD) of CD23
is involved in binding to either ligand (Bettler et al., 1989).
Similarly, carbohydrate-specific MAbs can also recog-
nize polypeptides, apparently due to occupation of the
same antigen binding domain with either ligand (Valadon
et al., 1996). A series of experimental data provides a
similar view of Ly-49A interaction with Dd and carbohy-
drate. We have demonstrated that anti-Ly-49A MAbs
interfere with carbohydrate binding. In addition, the anti-
Ly-49A MAbs recognize overlapping epitopes on Ly-
49A by cross-competition assays, and all block the inter-
action between Ly-49A and Dd (Brennan et al., 1996)
(N. M. and W. M. Y., unpublished data). Indeed, the A1,
YE1/32, and YE1/48 MAbs all recognize the CRD of Ly-
49A (Brennan et al., 1996). Although it is always possible
that the antibodies could be interfering by steric or allo-
steric effects, and the stalk region of the Ly-49A is also
involved in MHC class I specificity (Brennan et al., 1996),
the data are consistent with the interpretation that Ly-
49A utilizes its CRD to recognize both of its ligands.
Previous studies with tunicamycin-treated target cells
(Daniels et al., 1994b) need to be reconciled with the
current findingsand interpretations.Although tunicamycin
treatment of targets appears to inhibit Ly-49A recogni-
tion, tunicamycin treatment affects N-linked carbohy-
drate addition to all glycoproteins. In contrast, the effect
of Asn mutations of Dd should be restricted to only Dd,
allowing specific examination of its interaction with
Ly-49A, as we have demonstrated here. Existing experi-
mental strategies to evaluate the consequences of
Ly-49A±Dd interaction require use of functional assays
involving cell±cell contact, like cytotoxicity or binding.
Such assays may be influenced by other lectin±carbo-
hydrate interactions that may help tostabilize Ly-49A±H-
2Dd recognition, in the same way that integrins indirectly
augment T cell±APC interaction resulting in optimal T
cell receptor recognition in functional assays (Dustin
and Springer, 1991). Similarly, natural killing could be
Figure 4. Expression of Intradomain Recombinant MHC Class I Mol-affected by carbohydrates on targets that bind to the
eculesmyriad NK cell lectin-like receptors, which may be either
(A) Crossover points between Dd and Kd in intradomain recombinantactivating or inhibitory (Yokoyama and Seaman, 1993).
molecules. The contribution of Dd is indicated by the open boxes,
Even though Dd recognition by Ly-49A is carbohydrate- whereas Kd is represented by the shaded box (Abastado et al., 1987).
independent, tunicamycin effects may be misleading A schematic representation of the domains of a typical MHC class
because of consequences on other molecular interac- I molecule is diagrammed above. Positions of the last residues,
which are derived from Kd and are distinct from Dd, are shown attions required to detect the Ly-49A±H-2Dd recognition
the recombination sites.event, whether binding or inhibition of cytotoxicity.
(B) Transfected expression of intradomain recombinant MHC classAlthough it is not currently possible to examine the Ly-
I molecules. C1498 cells were stably transfected with the chimeric
49A±H-2Dd interaction more directly with recombinant constructs. Representative transfected clones were stained with
soluble molecules, because of markeddifficulties in pro- anti-Dd a3 domain antibody (34-2-12) (bold line) or isotype-matched
ducing soluble Ly-49A molecules (N. M. and W. M. Y., control antibody (MAR) (dotted line) and then stained with FITC-
goat anti-mouse IgG F(ab9)2 fragments.unpublished data), such studies may ultimately provide
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inhibitory, suggesting that residues 90±107 in the R5±R6
interval contributed to Ly-49A recognition. In all of these
regions, there are several residues that are polymorphic
between Dd and Kd (Figure 7). These residues may con-
tribute to Ly-49A recognition by direct interaction, or
effects on Dd itself, such as the capacity to bind peptides
or effect on overall conformation. However, the protec-
tive chimeric molecules still appeared to bind peptides
and undergo conformational changes, because they
were equally reactive with MAb 34-5-8S, which detects
a conformational epitope on Dd that is induced by the
presence of bound peptide (Otten et al., 1992) (N. M.
and W. M. Y., unpublished data). Currently, our results
do not exclude the possible involvement of other regions
of the MHC class I molecule, because conserved, non-
polymorphic residues between Dd and Kd may interact
with Ly-49A but would not be revealed in analysis of
recombinant molecules. The precise localization of Ly-
49A contacts will therefore require detailed site-directed
mutagenesis studies and ultimately, crystallographic
analysis of Ly-49A±H-2Dd complex, and this detailed
analysis will need to take the above considerations into
account. Nevertheless, the recombinant molecule analy-
Figure 5. Protective Activity of the Intradomain Recombinants from sis strongly suggests that Ly-49A recognition is influ-
Killing by Ly-49A1 LAK Cells
enced by a relatively large molecular surface of the a1
C1498 cells transfected with the intradomain recombinants were
domain and extreme amino terminus of the a2 domainlabeled with 51Cr and were subjected to a 4 hr killing assay by Ly-
of the Dd polypeptide (Figure 7).49A1 LAK cells (closed circles) or Ly-49A2 LAK cells (open circles).
The same set of intradomain recombinant moleculesRepresentative results from three independent experiments with
similar results are shown. has been used to map determinants recognized by Dd-
alloreactive CTL clones and serologic epitopes recog-
nized by MAbs. Interestingly, the CTL clones reacted
reconciliation of existing data and permit further explo- with the R1 but not with the R2 recombinant, suggesting
ration of the affinity between Ly-49A and its ligands. a role for residues 53±65 (Maryanski et al., 1989). The
While we must be cautious in interpreting the potency basis for this reactivity is not known, but this is also an
of effects of the various chimeric molecules, the results area that appears to contribute to Ly-49A specificity. In
provide a tentative localization of the Ly-49A recognition addition, there is a close relationship between the epi-
site(s) on Dd. Wild-type Dd was reproducibly more inhibi- tope recognized by anti-Dd a1/a2 domain±specific MAb
tory than the chimeric molecules, suggesting that Ly- 34-5-8S and determinants recognized by Ly-49A. This
49A recognizes residues within the 1±52 region. The R1 MAb inhibits recognition of Dd by Ly-49A in both func-
recombinant was less potent than the R2 recombinant, tional killing and physical binding assays. Moreover,
suggesting that residues 53±65 may have opposite ef- MAb 34-5-8S reacts with the R1±R5 recombinants but
fects on Ly-49A recognition. Chimeric molecules R3, not the R6 molecules (Abastado et al., 1987), a pattern
identical to Ly-49A recognition, and involving at leastR4, and R5 produced similar results, while R6 was not
Figure 6. Ly-49A Specificity of the Inhibitory
Effect of the Intradomain Recombinant MHC
Class I Molecules
The assays were performed as described in
the legend for Figure 5. The data are from one
of two independent experiments with similar
results.
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Figure 7. Schematic Presentation of the a1/a2 Region of H-2Dd
A molecular model of Dd (Corr et al., 1993) is displayed as a ribbon structure with amino acid side chains shown for those residues (2, 17, 22,
23, 24, 30, 32, 41, 45, 49, 50, 52, 62, 63, 65, 69, 70, 73, 95, 97, 99, 104, and 107) that differ between Dd and Kd in the amino terminus (before
the R1 breakpoint), the R1±R3 interval, and the R5±R6 interval. Residues for N-linked glycosylation (86 and 176) are also labeled. (A) View
from above in the classic orientation and (B) orthogonal view where the presentation in (A) was rotated 908 to the left. The figures were
generated with SETOR (Evans, 1993).
the interval between the R5 and R6 crossovers. In an overlapping recognition sites provide evidence against
the possibility that the two types of receptors are core-analysis of recombinant Ld and Dd molecules, thebinding
site of MAb 34-5-8S can also be localized to this region ceptors in terms of recognition of the same MHC class
I molecule, such as the TCR and CD8 (Janeway, 1992).(McCluskey et al., 1986). Furthermore, recognition by
Ly-49A and efficient binding of 34-5-8S both require the On the other hand, these data suggest that NK cell
receptors can together sample a large area of MHCpresence of a peptide in the peptide-binding groove on
Dd (Otten et al., 1992; Orihuela et al., 1996). Finally, like class I molecules.
Ly-49A can bind the polysaccharides fucoidan andLy-49A, recognition of Dd by 34-5-8S appears to be unaf-
fected by N-glycosylation mutations (N. M. and W. M. Y., dextran sulfate (Daniels et al., 1994b) (N. M. and W. M. Y.,
unpublished data), whereas Ly-49C recognizes fu-unpublished data). Thus, at least one determinant recog-
nized by Ly-49A is involved in alloreactive TCR recogni- coidan, dextran sulfate, and lambda-carrageenan (Bren-
nan et al.,1995). However, thesecomplex carbohydratestion, and another is a serological epitope.
Inasmuch as it now appears that mouse and human are not physiologic mouse ligands. Small sulfate- or
phosphate-containing monosaccharides can interfereNK cells bear both lectin-like and Ig-like receptors and
that an individual NK cell may express multiple recep- with binding of Ly-49A molecules to the complex sugars
(Daniels et al., 1994b), suggesting that these complextors, an understanding of the relationship of their speci-
ficity will be helpful in elucidating their functional con- sugars may mimic physiologic ligands made up of these
smaller subunits. The exploration for physiologic carbo-nection. The type I, Ig-like KIR molecules recognize
residues 73, 76, 80, and 90 in the a1 domain (Colonna hydrate ligands for Ly-49 receptors, and for the human
lectin-like NK cell receptors, CD94/NKG2, may provideet al., 1993; Gumperz et al., 1995; Mandelboim et al.,
1997). These sites, particularly residue 73, overlap the opportunities to evaluate the role of carbohydrates in
affecting NK cell function. It is possible that certain tar-putative recognition sites for Ly-49A, strongly sug-
gesting that a single MHC class I molecule could not gets may be protected from NK cell lysis because the
display of putative carbohydrate ligands may inhibit NKsimultaneously interact with both types of NK cell recep-
tors. Interestingly, residue 74 has been implicated in cell activity. Certain microorganisms, for example, may
escape NK cell activity by display of such carbohydratesthe resistance of HLA class I molecules against bulk
populations of human NK cells (Storkus et al., 1991), similar to viral evasion from NK cells in herpes virus
infections due to expression of viral MHC class I homo-despite the large repertoire of NK cell receptors and
their overlapping expression on NK cell subsets. This logs (Farrell et al., 1997; Reyburn et al., 1997). Also,
tumor cells may escape destruction because of aberra-site could affect a determinant that is recognized by
both typesof NK cell receptors, regardless of specificity. tions in carbohydrate display on the cell surface (Feizi,
1985). Since most mouse and human NK cells expressAlthough the data do not rule out other relationships
between these receptors, and the detailed specificity one or multiple lectin-like inhibitory receptors, these
mechanisms may provide a means to inhibit a largeof individual receptors simultaneously expressed on a
single NK cell is just beginning to be elucidated, these number of effector cells with a complex carbohydrate.
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(Indianapolis, IN). Protein A±Sepharose and protein G±SepharoseIn this regard, the overall findings of two potential
were from Pharmacia (Uppsala, Sweden).ligands have implications for therapeutically regulating
NK cell activity. Human and mouse NK cells express
Derivation of N-Glycosylation Mutants and Stable
multiple receptors belonging to the C-type lectin super- Transfection of C1498 Cells
family,and there is promiscuous binding of these recep- Wild-type H-2Dd cDNA was initially obtained by PCR amplification
tors to MHC class I ligands. Blockade of MHC class I of cDNA derived from DBA/2J (H-2d) with primers from the published
Dd gene product (Pullen et al., 1992), and was subcloned into theligand binding by peptide mimics or by anti-receptor
mutagenesis vector pSELECT-1 (Promega, Madison, WI). The N86Qantibodies may be difficult because of the large reper-
and N176Q H-2Dd point mutants were generated by site-directedtoire of NK cell receptors and MHC ligands. However,
mutagenesis of Dd in pSELECT-1 (pDdSEL.12) using the manufactur-
if a small number of carbohydrates bind these lectin- er's protocol. Briefly, single-stranded plasmid was generated from
like receptors, this will provide another approach to alter pDdSEL.12 by superinfection of transfected Escherichia coli JM109
NK cell recognition of MHC ligands and enhance NK cells with R408 helper phage. The single-stranded plasmid con-
taining antisense cDNA sequence of Dd was hybridized to the muta-cell activity. Interestingly, Ly-49A and Ly-49C molecules
genic oligonucleotide 59-GCCGCCCGCGCTCTGTTGGTAGTAGCGhave distinct MHC class I ligands but can bind overlap-
CAG-39 (N86Q) or 59-GCGCAGCAGCGTAGCTTGCCCGTTCTTCAG-39ping subsets of complex carbohydrates (Daniels et al.,
(N176Q), as well as to an oligonucleotide that repairs a defective
1994b; Brennan et al., 1995). With the caveat that the ampicillin resistance gene in pSELECT-1. Second-strand synthesis
carbohydrates may also affect the lectin-like NK cell was initiated with T4 DNA polymerase. The Dd double mutant
receptors that have the opposing function (capacity to (N86,176Q) was made by the same procedure by hybridizing both
mutagenic oligonucleotides as well as the ampicillin repair oligonu-activate), such as the NKR-P1 family of molecules (Yo-
cleotide to the single-stranded DNA in the same reaction. Followingkoyama and Seaman, 1993), the exploration of carbohy-
treatment with T4 ligase, plasmids were transfected into E. colidrate ligands for NK cell receptors may be rewarded
BMH 71-18 mut S. Following transfection and selection in ampicillin,
with development of new therapeutic agents to enhance plasmids were isolated and retransfected into JM109. All mutations
(or depress) NK cell activity. were confirmed by DNA sequence analysis using standard tech-
niques. Wild-type and mutated Dd cDNA were individually subcloned
into the eukaryotic expression vector, pHbAPr-1-neo, which directsExperimental Procedures
expression of cDNAs by the human b-actin promoter (Gunning et
al., 1987). C1498 cells were transfected by electroporation and se-Cells and Cell Lines
lected as described previously (Karlhofer et al., 1992).C1498 cells (H-2b lymphoma) and Chinesehamster ovary (CHO) cells
were obtained from the American Type Culture Collection (ATCC,
Rockville, MD) and maintained in RPMI 1640 medium supplemented FACS Analysis
with 10% FCS (Life Technologies, Gaithersburg, MD), 2 mM gluta- For standard FACS analysis, 2 3 105 cells were incubated with
mine, penicillin, streptomycin, 0.5 mM 2-mercaptoethanol, and 25 saturating concentrationsof antibodies for 20 min at48C. After wash-
mM HEPES. C1498-Dd and C1498 cells transfected with the Dd mu- ing with FACS buffer, HBSS with 0.1% BSA (Sigma), and 0.1%
tants were maintained in the same medium in the presence of 0.5 sodium azide (Sigma), the cells were then incubated with 10 mg/ml
mg/ml of G418 (Life Technologies). C1498 cells transfected with of FITC-goat anti-mouse IgG F(ab9)2 fragments for 20 min at 48C.
H-2Kd were previously described (Karlhofer et al., 1992). The CHO The stained cells were analyzed on FACScanE or FACSCaliburE
cells stably transfected with Ly-49A cDNA (clone S167) were pre- with Cell QuestE software (Becton-Dickinson, San Jose, CA). Dead
viously described (Daniels et al., 1994a) and maintained in alpha cells stained by propidium iodide were excluded.
medium without deoxyribonucleic acid and ribonucleic acid supple- Fluorescein-conjugated fucoidan (Fl-fucoidan) was prepared with
mented with 10% dialyzed FCS (Sigma, St. Louis, MO), 2 mM gluta- cyanogen bromide (Sigma) as described(Glabe et al., 1983). Binding
mine, penicillin, streptomycin, and 6 mM methotrexate (Sigma). T of Fl-fucoidan was performed as described previously but with minor
cell±depleted Ly-49A1 and Ly-49A2 LAK cells were prepared from modifications (Daniels et al., 1994b). 105 cells in FACS buffer were
spleen cells from C57BL/6 mice (Taconic, Germantown, NY) and preincubated with indicated concentration of carbohydrates or anti-
were used for cytotoxicity assay on day 9 or 10 of culture, at least bodies for 20 min then incubated with indicated concentrations of
3 days after separation by MAb A1 reactivity as described (Karlhofer fluorescein-labeled fucoidan for 1 hr at 48C. The cells were diluted
et al., 1992). Ly-49A1 LAK were always more than 95% positive for 10 times with FACS buffer containing 1 mg/ml of propidium iodide
Ly-49A and Ly-49A2 LAK cells contained less than 1% Ly-49A1 just prior to analysis. The cells were analyzed as described above.
cells by FACS analysis with MAb A1 (anti-Ly-49A). Inhibition of binding of FITC-labeled anti-Ly-49A antibodies by fu-
coidan was performed by preincubation with indicated carbohy-
drates for 20 min at 48C followed by incubation with each of theAntibodies and Other Reagents
FITC-labeled antibodies. The results were expressed as percentageAll antibodies were purified using protein A or protein G affinity
of mean fluorescence intensity in the absence of inhibitors, afterchromatography from culture supernatants. Clones 34-5-8S (anti-
subtraction of nonspecific binding (measured in the presence ofDd a1, a2 domain), 34-2-12 (anti-Dd a3 domain), and MAR18.5 (anti-
excess amount of unlabeled antibodies).rat kappa chain) were obtained from the ATCC and are all mouse
IgG2a. Clone A1 (anti-Ly-49A, mouse IgG2a) was previously de-
scribed (Nagasawa et al., 1987). YE1/32 (anti-Ly-49A, rat IgG), YE1/ Cell-Surface Biotinylation and Immunoprecipitation
Cells were surface-biotinylated using NHS-LC-biotin (Pierce, Rock-48 (anti-Ly-49A, rat IgG), and JR9.318 (anti-Ly-49A, Mus spretus IgG)
were the kind gifts of Fumio Takei (University of British Columbia, ford, IL) as previously described (Altin and Pagler, 1995). The cells
were then solubilized in 50 mM Tris±HCl buffer (pH 8.0) with 0.5%Vancouver, Canada) and Jacques Roland (Pasteur Institute, Paris,
France), respectively (Chan and Takei, 1986; Roland and Cazenave, Nonidet P-40, 150 mM NaCl, 1 mM PMSF, and CompleteE protease
inhibitor cocktail at the concentration suggested by the manufac-1992). F(ab9)2 fragments were prepared by limited digestion of puri-
fied antibodies by pepsin, followed by affinity purification using turer. Nuclei were removed by centrifugation at 12,000 3 g for 20
min. The postnuclear lysates from 107 cells were precleared byprotein A and protein G affinity column chromatography. Antibodies
were conjugated with FITC-Celite (Calbiochem, San Diego, CA) with incubating with irrelevant antibodies (MAR) and protein G±Seph-
arose and then subjected to immunoprecipitation with 10 mg of 34-a standard protocol (Coligan et al., 1996). FITC-labeled goat anti-
mouse IgG F(ab9)2 was obtained from Organon Teknika (Durham, 2-12 and 10 ml of protein G±Sepharose. The Sepharose beads were
washed three times with 20 mM Tris±HCl buffer (pH 7.5) with 0.1%NC). Iodoacetamide,PMSF, poly-L-Lysine, andBSA were purchased
from Sigma. N-glycosidase F, CompleteE protease inhibitors cock- Nonidet P±40, 150 mM NaCl, 1 mM EDTA, and 1 mM PMSF and
then eluted with 20 mM sodium phosphate (pH 7.2), 1% SDS, andtail and Nonidet P-40 were purchased from Boehringer Mannheim
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10 mM iodoacetamide on boiling water for 3 min. The eluates were Brennan, J., Takei, F., Wong, S., and Mager, D.L. (1995). Carbohy-
drate recognition by a natural killer cell receptor, Ly-49C. J. Biol.diluted 10 times with 20 mM sodium phosphate (pH 7.2), 0.5%
Nonidet P-40, 1 mM EDTA, and 1 mM PMSF. For deglycosylation, Chem. 270, 9691±9694.
aliquots were incubated with 0.4 U of N-glycosidase F for 16 hr. Brennan, J., Mahon, G., Mager, D.L., Jefferies, W.A., and Takei,
The immunoprecipitates were separated on 10% SDS±polyacryl- F. (1996). Recognition of class I major histocompatibility complex
amide gel and transferred to Immobilon P membrane (Millipore). molecules by Ly-49: specificities and domain interactions. J. Exp.
Biotinylated protein bands were visualized by streptavidin-HRP and Med. 183, 1553±1559.
ECL (Amersham) reaction. Burshtyn, D.N., Scharenberg, A.M., Wagtmann, N., Rajagopalan, S.,
Berrada, K., Yi, T., Kinet, J.P., and Long, E.O. (1996). Recruitment
Cytotoxicity Assay of tyrosine phosphatase HCP by the killer cell inhibitor receptor.
Standard 51Cr-release assays were performed as previously de- Immunity 4, 77±85.
scribed (Karlhofer and Yokoyama, 1991). Briefly, 104 of 51Cr-labeled
Carretero, M., Cantoni, C., Bellon, T., Bottino, C., Biassoni, R., Rodri-target cells were incubated for 4 hr with Ly-49A1 or Ly-49A2 LAK
guez, A., Perezvillar, J.J., Moretta, L., Moretta, A., and LoÂ pez-Botet,cells at the indicated effector:target (E:T) ratios. When anti-Ly-49A
M. (1997). The CD94 andNKG2-A C-type lectins covalently assembleantibodies were included, LAK cells were incubated with the anti-
to form a natural killer cell inhibitory receptor for HLA class I mole-bodies for 20 min at ambient temperature before the addition of
cules. Eur. J. Immunol. 27, 563±567.target cells. When anti±MHC class I antibodies were included, target
Chan, P.Y., and Takei, F. (1986). Expression of a T cell receptor±likecells were preincubated with F(ab9)2 fragments of the antibodies for
molecule on normal and malignant murine T cells detected by rat20 min at ambient temperature. All the antibodies and their F(ab9)2
monoclonal antibodies to nonclonotypic determinants. J. Immunol.fragments were added at the final concentration of 10 mg/ml. Spe-
136, 1346±1353.cific cytotoxicity was calculated using standard formulas as pre-
Chan, P.Y., and Takei, F. (1989). Molecular cloning and characteriza-viously described (Karlhofer et al., 1992).
tion of a novel murine T cell surface antigen, YE1/48. J. Immunol.
142, 1727±1736.Cell Binding Assay
As described previously with minor modifications (Daniels et al., Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M., and
1994a), 2 3 104 Ly-49A1 CHO (S167) cells or untransfected CHO Strober, W. (1996). Current Protocols in Immunology (New York:
cells were cultured overnight to generate a uniform monolayer on Wiley).
96 flat-bottom plates precoated with 25 mg/ml of poly-L-Lysine. Colonna, M., Borsellino, G., Falco, M., Ferrara,G.B., and Strominger,
Target cells were fluorescently labeled by incubation with 10 mM J.L. (1993). HLA-C is the inhibitory ligand that determines dominant
Calcein-AM (Molecular Probes, Eugene, OR) for 1 hr, then washed resistance to lysis by NK1- and NK2-specific natural killer cells.
three times with HBSS with 1% BSA. 7.5 3 104 of the target cells Proc. Natl. Acad. Sci. USA 90, 12000±12004.
were incubated on S167 or CHO cell monolayer for 1 hr at 378C.
Colonna, M., and Samaridis, J. (1995). Cloning of immunoglobulin-When indicated, cell monolayers were preincubated with carbohy-
superfamily members associated with HLA-C and HLA-B recogni-drates or antibodies for 20 min at 378C before the addition of the
tion by human natural killer cells. Science 268, 367±368.target cells. Wells were then completely filled with PBS and taped,
Corr, M., Boyd, L.F., Padlan, E.A., and Margulies, D.H. (1993). H-2Ddand unbound target cells were removed by centrifugation of inverted
exploits a four residue peptide binding motif. J. Exp. Med. 178,plates at 300 3 g for 4 min. Bound fluorescence was measured
1877±1892.with a fluorescence microplate reader FL-500 (Bio-Tek Instruments,
Correa, I., and Raulet, D.H. (1995). Binding of diverse peptides toWinooski, VT) with excitation wave length of 490 nm and emission
MHC class I molecules inhibits target cell lysis by activated naturalwave length of 515 nm. Percentage of specifically bound target cells
killer cells. Immunity 2, 61±71.was calculated as described (Daniels et al., 1994a).
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